Stay updated on HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s display/release revision indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/version change without affecting the study information content.
    Difference
    0.1%
    Check dated 2026-04-24T04:28:07.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T21:36:25.000Z thumbnail image
  3. Check
    39 days ago
    Change Detected
    Summary
    The site version label was updated to Revision: v3.5.0 with the previous Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-18T20:40:03.000Z thumbnail image
  4. Check
    46 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This change does not modify study details, eligibility criteria, or page functionality.
    Difference
    0.0%
    Check dated 2026-03-11T17:20:08.000Z thumbnail image
  5. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The older Revision: v3.4.1 entry and the government funding notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:48:35.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center status was added. The site version was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T07:56:18.000Z thumbnail image

Stay in the know with updates to HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.